Literature DB >> 20947458

Ethanol sclerotherapy with 'injection and aspiration technique' for giant lymphatic malformation in adult cases.

Hiroshi Furukawa1, Satoru Sasaki, Akihiko Oyama, Toshihiko Hayashi, Emi Funayama, Noriko Saito, Yuhei Yamamoto.   

Abstract

Ethanol is a commonly used sclerosant for lymphatic malformation (LM), and recent evidence has shown that macrocystic LMs respond very well to percutaneous sclerotherapy. However, the volume of absolute ethanol that can be injected safely is small (0.5-1 ml/kg), and that is the reason it is often ineffective in extensive LM. We report two cases of giant LM with occasional high fever and pain or abnormal gait. To overcome dose limitation and to prevent systematic toxicities, we performed both injection of absolute ethanol and aspiration of it after 5 min exposure to LM. The injected maximum ethanol dose per one session is 70-260 ml and no systemic complication occurred. The 1-3 sessions of those procedures reduced the frequency of high fever and improved the swelling of those lesions. The injection and aspiration technique maximises the efficacy of sclerotherapy for extensive macrocystic LM in adults.
Copyright © 2010 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947458     DOI: 10.1016/j.bjps.2010.09.003

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  2 in total

1.  Chemical ablation therapy of recurrent mediastinal nodal metastasis in post-radiotherapy cancer patients.

Authors:  Xinglu Xu; Xiuling Li; Xin Ye; Gang Liu; Jun Wang; Zhaohui Peng; Tian Liang; Wei Yang; Xiaoguang Hao
Journal:  Med Oncol       Date:  2014-09-10       Impact factor: 3.064

2.  Treatment of deep-seated facial microcystic lymphatic malformations with intralesional injection of pingyangmycin.

Authors:  Hai Wei Wu; Xuan Wang; Jia Wei Zheng; Hai Guang Zhao; Jing Ge; Ling Zhang; Yan An Wang; Li Xin Su; Xin Dong Fan
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.